BioRevolution is pioneering a new approach to muscle health by reprogramming metabolic pathways to build, restore, and preserve muscle mass and strength for longevity. Its first-in-class, oral small molecule program, BREV-100, is designed to reduce glycogen accumulation, correct metabolic dysfunction, and restore functional muscle strength with initial focus in Pompe disease and broad applicability across multiple indications, including Glycogen Storage Diseases, Muscular Dystrophies, and Sarcopenia.